companydata.dkcompanydata.dk

FERRING LÆGEMIDLER A/S: Financial statements 2024

CVR: 16313491

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

FERRING LÆGEMIDLER A/S (CVR 16313491) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 6,279,000 and a net result of DKK 1,234,000 compared with DKK 1,155,000 the year before. That is a decrease of 8.1% compared with the year before. Equity in the 2024 report amounted to DKK 9,858,000. The solvency ratio was 25.8%. The company had 3 employees in the financial year.

Gross Profit
DKK 6,279,000
Profit/Loss
DKK 1,234,000
Equity
DKK 9,858,000
Total Assets
DKK 38,147,000
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-6.3M1.2M9.9M3
2023-6.8M1.2M8.6M3
2022-5.7M1.5M12M2
2021-7.1M2.6M10.4M2
2020-15.1M1.1M7.9M10

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Jenise Ryann Doutsas joins the board of FERRING LÆGEMIDLER A/SDec 10, 2024

As of December 10, 2024, Jenise Ryann Doutsas has joined the board of directors of FERRING LÆGEMIDLER A/S.

Lasse Juul Jakobsen leaves the board of FERRING LÆGEMIDLER A/SDec 10, 2024

As of December 10, 2024, Lasse Juul Jakobsen has left the board of directors of FERRING LÆGEMIDLER A/S.

FERRING LÆGEMIDLER A/S wins public contractNov 29, 2024

FERRING LÆGEMIDLER A/S has won the tender "Amgros 2025 1.1163.a" issued by Amgros I/S worth 1,644,000,000 DKK.

FERRING LÆGEMIDLER A/S wins public contractOct 24, 2024

FERRING LÆGEMIDLER A/S has won the tender "Amgros 2025 1.700.a" issued by Amgros I/S worth 313,301,544 DKK.

FERRING LÆGEMIDLER A/S wins public contractOct 21, 2024

FERRING LÆGEMIDLER A/S has won the tender "Amgros 2025 1.706.b" issued by Amgros I/S worth 25,800,000 DKK.

Mario Alejandro Esteves Durand joins the board of FERRING LÆGEMIDLER A/SAug 7, 2024

As of August 7, 2024, Mario Alejandro Esteves Durand has joined the board of directors of FERRING LÆGEMIDLER A/S.

Valerio Trifoni leaves the board of FERRING LÆGEMIDLER A/SAug 7, 2024

As of August 7, 2024, Valerio Trifoni has left the board of directors of FERRING LÆGEMIDLER A/S.

Maja Lassenius Kramp joins FERRING LÆGEMIDLER A/S as adm. dir.Jul 30, 2024

As of July 30, 2024, Maja Lassenius Kramp is registered as adm. dir. of FERRING LÆGEMIDLER A/S.

Morten Vaupel steps down as adm. dir. of FERRING LÆGEMIDLER A/SJul 30, 2024

As of July 30, 2024, Morten Vaupel has stepped down as adm. dir. of FERRING LÆGEMIDLER A/S.

FERRING LÆGEMIDLER A/S: The 2023 annual report is outJun 28, 2024

FERRING LÆGEMIDLER A/S has published its annual report for 2023. Gross profit came to DKK 6,832,000, and the net result was DKK 1,155,000.

About FERRING LÆGEMIDLER A/S

FERRING LÆGEMIDLER A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1992. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE 38 NR. 1586. The management consists of Maja Lassenius Kramp. The board consists of Kjell Thomas Larsson (chair), Eric Michel Breumier and Valerio Trifoni. The company is owned by Ferring B.V.. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 6,653,000 and a net result of DKK 1,371,000 compared with DKK 1,234,000 the year before. Equity in the 2025 report amounted to DKK 11,229,000.

Source: annual report 2025, Danish Business Authority